questionsmedicales.fr
Phénomènes génétiques
Phénotype
Sérogroupe
Sérogroupe : Questions médicales fréquentes
Termes MeSH sélectionnés :
Sensitivity and Specificity
Diagnostic
5
Test ELISA
Immunofluorescence
Culture bactérienne
Identification des microorganismes
PCR
Détection des agents pathogènes
Historique médical
Évaluation clinique
Symptômes
5
Variabilité des symptômes
Sérogroupe
Complications
Gravité des symptômes
Évolution des symptômes
Traitement
Prévention
5
Prévention des infections
Hygiène
Efficacité des vaccins
Prévention
Hygiène
Prévention des infections
Voyages
Exposition aux infections
Comportements à risque
Prévention
Traitements
5
Traitement spécifique
Sérogroupe
Vaccins
Prévention des infections
Suivi médical
Efficacité du traitement
Médecine complémentaire
Traitements alternatifs
Complications
5
Septicémie
Complications infectieuses
Prévention des complications
Traitement précoce
Complications graves
Mortalité
Signes d'alerte
Complications
Facteurs de risque
5
Facteurs de risque
Immunodépression
Antécédents médicaux
Risque d'infection
Mode de vie
Prévention des infections
Voyages
Exposition aux infections
Conditions environnementales
Risque d'infection
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Sérogroupe : Questions médicales les plus fréquentes",
"headline": "Sérogroupe : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Sérogroupe : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-30",
"dateModified": "2025-04-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Sérogroupe"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénotype",
"url": "https://questionsmedicales.fr/mesh/D010641",
"about": {
"@type": "MedicalCondition",
"name": "Phénotype",
"code": {
"@type": "MedicalCode",
"code": "D010641",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.695"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Sérogroupe",
"alternateName": "Serogroup",
"code": {
"@type": "MedicalCode",
"code": "D065288",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ray Borrow",
"url": "https://questionsmedicales.fr/author/Ray%20Borrow",
"affiliation": {
"@type": "Organization",
"name": "Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom."
}
},
{
"@type": "Person",
"name": "Bo Pang",
"url": "https://questionsmedicales.fr/author/Bo%20Pang",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. pangbo@icdc.cn."
}
},
{
"@type": "Person",
"name": "Biao Kan",
"url": "https://questionsmedicales.fr/author/Biao%20Kan",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. kanbiao@icdc.cn."
}
},
{
"@type": "Person",
"name": "Lucy A McNamara",
"url": "https://questionsmedicales.fr/author/Lucy%20A%20McNamara",
"affiliation": {
"@type": "Organization",
"name": "Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, USA."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "AUCReshaping: improved sensitivity at high-specificity.",
"datePublished": "2023-11-30",
"url": "https://questionsmedicales.fr/article/38036602",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-48482-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Meta-analysis assessing the sensitivity and specificity of",
"datePublished": "2023-03-18",
"url": "https://questionsmedicales.fr/article/36934977",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ahj.2023.03.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sensitivity and specificity of Varian Halcyon's portal dosimetry for plan-specific pre-treatment QA.",
"datePublished": "2023-04-22",
"url": "https://questionsmedicales.fr/article/37086428",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/acm2.14001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Specific recognition and sensitive quantification of mRNA splice variants",
"datePublished": "2023-11-06",
"url": "https://questionsmedicales.fr/article/37818948",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d3an01382k"
}
},
{
"@type": "ScholarlyArticle",
"name": "Estimating stage-specific sensitivity for cancer screening tests.",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36734139",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/09691413231154801"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénotype",
"item": "https://questionsmedicales.fr/mesh/D010641"
},
{
"@type": "ListItem",
"position": 4,
"name": "Sérogroupe",
"item": "https://questionsmedicales.fr/mesh/D065288"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Sérogroupe - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Sérogroupe",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Sérogroupe",
"description": "Comment identifier un sérogroupe spécifique ?\nQuels tests sont utilisés pour le diagnostic ?\nPeut-on diagnostiquer par culture ?\nLes tests PCR sont-ils utiles ?\nQuel rôle joue l'historique médical ?",
"url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Sensitivity+and+Specificity#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Sérogroupe",
"description": "Quels symptômes sont associés aux infections par sérogroupe ?\nLes symptômes varient selon le sérogroupe ?\nY a-t-il des symptômes communs ?\nLes symptômes peuvent-ils être graves ?\nComment les symptômes évoluent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Sensitivity+and+Specificity#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Sérogroupe",
"description": "Comment prévenir les infections par sérogroupe ?\nLes vaccins sont-ils efficaces ?\nQuelles mesures d'hygiène sont recommandées ?\nLes voyages augmentent-ils le risque ?\nLes comportements à risque à éviter ?",
"url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Sensitivity+and+Specificity#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Sérogroupe",
"description": "Quels traitements sont disponibles pour les infections ?\nLes traitements varient-ils selon le sérogroupe ?\nLes vaccins sont-ils disponibles ?\nComment évaluer l'efficacité du traitement ?\nY a-t-il des traitements alternatifs ?",
"url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Sensitivity+and+Specificity#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Sérogroupe",
"description": "Quelles complications peuvent survenir ?\nLes complications varient-elles selon le sérogroupe ?\nComment prévenir les complications ?\nLes complications peuvent-elles être mortelles ?\nQuels signes indiquent des complications ?",
"url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Sensitivity+and+Specificity#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Sérogroupe",
"description": "Quels sont les facteurs de risque d'infection ?\nLes antécédents médicaux influencent-ils le risque ?\nLe mode de vie joue-t-il un rôle ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes conditions environnementales influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Sensitivity+and+Specificity#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un sérogroupe spécifique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des tests sérologiques qui détectent des anticorps spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et l'immunofluorescence sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer par culture ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la culture de microorganismes peut aider à identifier le sérogroupe."
}
},
{
"@type": "Question",
"name": "Les tests PCR sont-ils utiles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la PCR peut détecter des séquences spécifiques de l'ADN des microorganismes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique aide à orienter les tests et à identifier les sérogroupes possibles."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux infections par sérogroupe ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient, mais incluent fièvre, douleurs et inflammation."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon le sérogroupe ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque sérogroupe peut provoquer des symptômes spécifiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes communs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue et la fièvre sont souvent communs."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être graves ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains sérogroupes peuvent entraîner des complications graves."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent s'aggraver rapidement sans traitement approprié."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par sérogroupe ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par la vaccination, l'hygiène et l'évitement des contacts à risque."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent réduire significativement le risque d'infection."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter les contacts avec des malades."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à risque peut augmenter l'exposition aux sérogroupes."
}
},
{
"@type": "Question",
"name": "Les comportements à risque à éviter ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les foules et les contacts étroits avec des personnes malades."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques ou antiviraux sont souvent utilisés selon le sérogroupe."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le sérogroupe ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque sérogroupe peut nécessiter un traitement spécifique."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils disponibles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains sérogroupes ont des vaccins pour prévenir les infections."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par le suivi des symptômes et des tests sérologiques après traitement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements complémentaires peuvent être envisagés, mais doivent être validés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la septicémie ou des infections localisées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le sérogroupe ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque sérogroupe peut entraîner des complications spécifiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce et approprié peut réduire le risque de complications."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être mortelles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent être graves et potentiellement mortelles."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une aggravation des symptômes ou une nouvelle fièvre doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, l'immunodépression et les conditions de vie."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'infections augmentent le risque de réinfection."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques expose à des sérogroupes spécifiques."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme la pollution ou le surpeuplement peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/04/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
University of Manchester, Infection, Immunity & Respiratory Medicine, School of Biological Sciences, Stopford Building, Manchester, United Kingdom.
3 publications dans cette catégorie
Affiliations :
State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. pangbo@icdc.cn.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China. pangbo@icdc.cn.
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Affiliations :
State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. kanbiao@icdc.cn.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China. kanbiao@icdc.cn.
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Affiliations :
Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, USA.
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Affiliations :
National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Affiliations :
Vaccine Medical Development, Scientific & Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Affiliations :
Institut Pasteur, Invasive bacterial infections Unit and National Reference Centre for Meningococci and Haemophilus influenzae, Paris, France.
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Affiliations :
Institute for Hygiene and Microbiology, University of Würzburg, Josef-Schneider-Str. 2, 97080 Würzburg, Germany. Electronic address: vogel_u@ukw.de.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Animal Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Korea.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Korea.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Korea.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Division of Microbiology, Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Indian Council of Agricultural Research-National Institute of Veterinary Epidemiology and Disease Informatics, Yelahanka, Bengaluru, Karnataka, India.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Indian Council of Agricultural Research-National Institute of Veterinary Epidemiology and Disease Informatics, Yelahanka, Bengaluru, Karnataka, India.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Onderstepoort 0110, South Africa. lokisnyman@gmail.com.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Amsterdam UMC, University of Amsterdam, Netherlands Reference Laboratory for Bacterial Meningitis, The Netherlands.
Publications dans "Sérogroupe" :
The evaluation of deep-learning (DL) systems typically relies on the Area under the Receiver-Operating-Curve (AU-ROC) as a performance metric. However, AU-ROC, in its holistic form, does not sufficien...
The use of...
To estimate the summary sensitivity and specificity of...
Studies were included if PET/CT was performed for suspicion of PVE and IPD of both the PET/CT result and final diagnosis defined by a gold-standard assessment was available. There were 3 possible fina...
Seventeen studies were included with IPD available for 537 patients (from 538 scans). The summary sensitivity and specificity were 85% (95% CI 74.2%-91.8%) and 86.5% (95% CI 75.8%-92.9%) respectively ...
Developed as a plan-specific pre-treatment QA tool, Varian portal dosimetry promises a fast, high-resolution, and integrated QA solution. In this study, the agreement between predicted fluence and mea...
All patient plans and the corresponding verification plans were generated within the Eclipse treatment planning system. Four representative plans of different treatment sites (prostate, prostate with ...
Predicted and acquired portal dosimetry fluences demonstrated a high agreement evident by average gamma passing rates for the clinical patient plans of 99.90%, 96.64%, and 91.87% for γ...
Owing to the high achievable spatial resolution, portal dosimetry at the Halcyon can reliably be deployed as plan-specific pre-treatment QA tool to screen for errors. It is recommended to support the ...
Specific recognition and sensitive quantification of mRNA alternative splice variants have been a necessity for exploring the regulatory mechanism of RNA splicing and revealing the association between...
When evaluating potential new cancer screening modalities, estimating sensitivity, especially for early-stage cases, is critical. There are methods to approximate stage-specific sensitivity in asympto...
We fit natural history models to lung and ovarian cancer screening data that permitted estimation of stage-specific (early/late) true sensitivity, defined as the probability subjects screened in the g...
Stage-specific true sensitivities estimated by the lung cancer natural history model were 47% (early) and 63% (late). Simulation results for the prospective setting gave estimated sensitivities of 81%...
Existing methods for approximating stage-specific sensitivity in both prospective and retrospective scenarios are unsatisfactory; improvements are needed before they can be considered to be reliable....
Recombinant proteins in complex solutions are typically detected with tag-specific antibodies in Western blots. Here we describe an antibody-free alternative in which tagged proteins are detected dire...
Children with cancer often present with general and nonspecific symptoms leading to initial diagnostic workup inclusive of clinical imaging. Various sequences of magnetic resonance imaging (MRI) are b...
Enzyme-linked immunosorbent assays (ELISAs) are a cornerstone of modern molecular detection, but the technique still faces notable challenges. One of the biggest problems is discriminating true signal...
To evaluate the sensitivity and specificity of the ABCD progression display for keratoconus progression....
Data was collected from patients that underwent at least two Pentacam assessments 6 months apart. Sensitivity and specificity were calculated for the ABCD progression display. Progression was defined ...
Thirty eyes were evaluated over a median time of 10.3 months. Progression by criterion 1 resulted in a sensitivity of 61.9% and specificity of 88.9%. Progression by criterion 2 resulted in higher sens...
The ABCD progression display can assess keratoconus progression with high sensitivity and specificity, thus assisting the patients' decision-making process. The D parameter did not contribute to the s...
To systematically evaluate the evidence for the reliability, sensitivity and specificity of existing measures of vowel-initial voice onset....
A literature search was conducted across electronic databases for published studies (MEDLINE, EMBASE, Scopus, Web of Science, CINAHL, PubMed Central, IEEE Xplore) and grey literature (ProQuest for unp...
The search retrieved 6,983 records. Titles and abstracts were screened against the inclusion criteria by two independent reviewers, with a third reviewer responsible for conflict resolution. Thirty-fi...
A range of vowel-initial voice onset measurements have been applied throughout the literature, however, there is a lack of evidence regarding their sensitivity, specificity and reliability in the dete...